Cardiac Valve Market Size Worth USD 15.56 Billion in 2032 | Emergen Research

The global cardiac valve market size was USD 6.87 Billion in 2022 and is expected to register a rapid revenue CAGR of 8.7% during the forecast period. Rising prevalence for cardiac diseases is a major factor driving market revenue growth.

Growing Prevalence of Cardiovascular Diseases

Cardiovascular diseases (CVDs) remain a leading cause of mortality worldwide, claiming approximately 17.9 million lives annually, as reported by the World Health Organization (WHO). Rheumatic heart disease, characterized by inflammation and scarring in the heart, particularly affects children in developing nations. Approximately 2% of cardiovascular disease-related deaths are attributed to rheumatic heart disease globally.

Market Drivers

The increasing geriatric population contributes significantly to the market's growth dynamics. With global demographics shifting, projections indicate that by 2030, one in six individuals will be aged 60 years or older, and by 2050, the population of individuals aged 60 years and older will reach 2.1 billion.

Moreover, recent advancements in cardiac valve replacement technologies have propelled market growth. Innovations such as transcatheter aortic valve replacement (TAVR) offer less invasive treatment options, enhancing patient outcomes and driving demand for cardiac valve interventions.

Clinical Trials and Innovations

Notable advancements include a clinical trial launched by The Minneapolis Heart Institute (MHIF) in collaboration with Edwards SAPIEN to evaluate transcatheter aortic valve replacement in patients with moderate calcific aortic stenosis. Such initiatives underscore the commitment of biotech companies and research organizations to continually enhance cardiovascular treatment options.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/2852

Market Restraints

Despite significant growth prospects, the market faces constraints such as the high cost of cardiac valve replacement procedures, particularly impacting patients in low-income countries. Additionally, the availability of alternative procedures, including balloon valvotomy and the Ross procedure, poses challenges to market expansion.

Market Segment Insights

Cardiac Valve Types: The market is segmented into mechanical valves, tissue valves, and transcatheter valves. Mechanical valves dominate the market due to their compatibility with diverse patient demographics, while tissue valves exhibit moderate growth attributed to rising preference for bioprosthetic valves.

Cardiac Valve Positions: Segmentation based on position includes mitral valve, aortic valve, and others. The mitral valve segment accounts for a significant market share owing to the rising need for mitral valve interventions and advancements in technologies. The aortic valve segment demonstrates steady growth, driven by technological advancements such as TAVR and increasing prevalence of aortic valve disorders.

Cardic Valve Market: Regional Share

Cardiac Valve North America Market

North America accounted for largest market share in the global cardiac valve market in 2022 due to rising prevalence of CVD in North America and increasing geriatric population. Cardiac valves adoptions are rapidly increasing owing to rising numbers CVDs in the U.S. According to American Heart Association, CVD remains as the leading cause of death in the U.S., accounted for 928,741 deaths in the year 2021. According to Canadian Institute for Health Information, around 2.4 million people in Canada have heart disease, which is the second leading cause of death in Canada.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/2852

Cardiac Valve Top Companies and Competitive Landscape
The global cardiac valve market is fragmented, with several key players accounting for the majority of market revenue. Major players are deploying various strategies, entering mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing new cardiac valve products.

Some major players included in the global cardiac valve market report are:
• Medtronic
• Edwards Lifesciences Corporation
• Boston Scientific Corporation
• LivaNova PLC
• Abbott
• Artivion, Inc.
• Colibri Heart Valve
• JenaValve
• TTK
• Symetis
• Lepu Medical Technology (Beijing) Co., Ltd.
• Braile Biomédica
• Labcor Laboratórios Ltd.
• Valcare Medical
• Perouse Medical,
• Meril Life Sciences Pvt. Ltd.
• CryoLife, Inc.
• MicroPort Scientific Corporation
• Foldax Inc.
• Novostia SA
• JC Medical, Inc.

Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.emergenresearch.com/industry-report/cardiac-valve-market

Cardiac Valve Latest Industry News

• On 5 October 2023, Artivion Inc., a leading cardiac and vascular surgery company announced the data from its On-X Aortic Heart Valve Low INR post-market study presented in a Late-Breaking Science session at the 37th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting in Vienna, Austria.

• On 7 May 2023, Edwards Lifesciences announced the new data from the COMMENCE aortic trial, demonstrating low rates of Structural Valve Deterioration (SVD) in bioprosthetic aortic valves with the company's innovative RESILIA tissue.
Cardiac Valve Segment Analysis

For the purpose of this report, Emergen Research has segmented the global cardiac valve market on the basis of treatment, type, position, end-use. and region:
• Treatment Outlook (Revenue, USD Billion; 2019-2032)
o Cardiac Valve Repair
o Cardiac Valve Replacement

• Type Outlook (Revenue, USD Billion; 2019-2032)
o Mechanical Valves
o Tissue Valves
o Transcatheter Valves

• Position Outlook (Revenue, USD Billion; 2019-2032)
o Mitral Valve
o Aortic Valve
o Others

• End-Use Outlook (Revenue, USD Billion; 2019-2032)
o Hospital
o Cardiac Research Institute
o Others

Request for Customization as per your specific Requirement @ https://www.emergenresearch.com/request-for-customization/2852

Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights

About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.